(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INOZYME

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

INOZYME

ST13

US500000090439231

Class

5

Filing

90439231

Registration

8069672

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

12/17/2025

Trademark type

Word

Nice classes

5

Filing date

12/31/2020

Registration date

12/16/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/16/2025

Last transaction

12/17/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/11/2025

First use in commerce

04/11/2025

Drawing code

4

Owner type

03

Owner location

Boston, MA

Examiner

MOSCATI,JUSTIN RONALD

Law office

N90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Inozyme Pharma, Inc.

Representatives

Gregory J. Chinlund Marshall, Gerstein & Borun LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

therapeutic pharmaceutical for the diagnosis and treatment of diseases or disorders afflicting the bonekidney and tissuediseases of abnormal mineralization and calcificationdiseases of the circulatory systemdiseases caused by inborn errors of metabolismdiseases caused by abnormal intimal proliferation; pharmaceutical products for use in the diagnosis and treatment of bonekidney and tissue diseasesdiseases of abnormal mineralization and calcificationdiseases of the circulatory systemdiseases caused by inborn errors of metabolismdiseases caused by abnormal intimal proliferation

Publications

History of USPTO decisions and trademark events.

48 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/16/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/16/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/26/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/26/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/21/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/21/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/19/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/19/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/19/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/19/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/19/2025

IUAF

USE AMENDMENT FILED

05/15/2025

EISU

TEAS STATEMENT OF USE RECEIVED

05/15/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/07/2024

EX5G

SOU EXTENSION 5 GRANTED

11/07/2024

EXT5

SOU EXTENSION 5 FILED

11/07/2024

EEXT

SOU TEAS EXTENSION RECEIVED

11/07/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/14/2024

EX4G

SOU EXTENSION 4 GRANTED

05/13/2024

EXT4

SOU EXTENSION 4 FILED

05/13/2024

EEXT

SOU TEAS EXTENSION RECEIVED

05/13/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/18/2023

EX3G

SOU EXTENSION 3 GRANTED

11/16/2023

EXT3

SOU EXTENSION 3 FILED

11/16/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/16/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/18/2023

EX2G

SOU EXTENSION 2 GRANTED

05/16/2023

EXT2

SOU EXTENSION 2 FILED

05/16/2023

EEXT

SOU TEAS EXTENSION RECEIVED

05/16/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/04/2022

EX1G

SOU EXTENSION 1 GRANTED

11/02/2022

EXT1

SOU EXTENSION 1 FILED

11/02/2022

EEXT

SOU TEAS EXTENSION RECEIVED

11/02/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/17/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/22/2022

PUBO

PUBLISHED FOR OPPOSITION

03/22/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/02/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/17/2022

DOCK

ASSIGNED TO EXAMINER

01/26/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/19/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/18/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/18/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/15/2021

GNRT

NON-FINAL ACTION E-MAILED

07/15/2021

CNRT

NON-FINAL ACTION WRITTEN

07/15/2021

DOCK

ASSIGNED TO EXAMINER

07/07/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/29/2021

NWAP

NEW APPLICATION ENTERED

01/04/2021

Continuous trademark protection

Get notified about every new filing that threatens INOZYME or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.